company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8328000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8328000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,61000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,856000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-820000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8189000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8189000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-120000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2400000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2280000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2280000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 13:16:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5906000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14908000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14908000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,20000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,702000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1471000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12663000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12663000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1514000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,130444000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1052000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,130905000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,130905000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000.0
Clovis Oncology Inc,CLVS,,0001466301,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,118244000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15668000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15668000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,498000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,625000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14483000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14483000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-19000.0
Clovis Oncology Inc,CLVS,,0001466301,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 12:14:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14463000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30718000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30718000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3477000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10667000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2960000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19534000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19534000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-220000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-220000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-220000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,123000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 13:43:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19574000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34764000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34764000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,80000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4505000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,834000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29345000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29345000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1689000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1689000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1689000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,706000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,706000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,706000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-94000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30422000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39642000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39642000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,143000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,72000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7565000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2360000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34222000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34222000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-282000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-282000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-282000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,278335000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,278335000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,278335000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-478000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,243353000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54907000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54907000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-3256000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,296000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20368000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3549000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33950000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33950000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-95000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-95000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-22000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,400000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,378000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,378000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-241000.0
Clovis Oncology Inc,CLVS,,0001466301,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-33908000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63144000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63144000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,769000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16458000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2657000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48405000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48405000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-816000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-142216000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-143032000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-143032000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1193000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1193000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1193000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-891000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-191135000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:15:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3714000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71531000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71531000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,182000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,804000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10623000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2696000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-57226000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-57226000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-190000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-190000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1880000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1880000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1880000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,255000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-55281000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98645000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98645000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,197000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,646000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23423000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2633000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-71746000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-71746000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-250324000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140996000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109497000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109497000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,300463000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,300463000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,300463000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-38000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,119182000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3593000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-119541000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-119541000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,213000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,386000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,93571000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-50318000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-75689000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-75689000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1860000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1859000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1859000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,944000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,944000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,944000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-83000.0
Clovis Oncology Inc,CLVS,,0001466301,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-76687000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-83400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-83400000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,387000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3533000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4528000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-83738000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-83738000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-604000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24396000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24396000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,705000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,705000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,705000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,254000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58383000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:30:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-129314000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-129314000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,280000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,380000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,108924000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-48202000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-67932000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-67932000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-152000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,74848000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,74848000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1238000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1238000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1238000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-148000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8006000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65695000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65695000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,269000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,351000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7032000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2292000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-60335000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-60335000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,65000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,75060000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,75060000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,659000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,659000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,659000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-39000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15345000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-70728000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-70728000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,322000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,335000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9565000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5831000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54675000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54675000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24995000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24995000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2574000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2574000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2574000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-67000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-365000.0
Clovis Oncology Inc,CLVS,,0001466301,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27538000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58464000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58464000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,639000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,531000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-19337000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3808000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-80439000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-80439000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2568000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-133000000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50000000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-86668000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-86668000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,226898000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,226898000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,226898000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,72000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,59863000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 13:09:56+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-175385000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-175385000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,642000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,349000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,140738000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35446000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-69102000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-69102000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-196000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47000000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47196000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47196000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,331542000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,331542000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,331542000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-72000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,215737000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60665000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60665000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,630000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,82000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-20302000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34470000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45785000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45785000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-167000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,163500000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,163333000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,163333000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1817000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1817000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1817000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,119686000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51883000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51883000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,593000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,671000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11327000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26286000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65578000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65578000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,2444000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1415000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-83500000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1100000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83571000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83571000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1818000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1818000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1818000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-886000.0
Clovis Oncology Inc,CLVS,,0001466301,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-148217000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-77694000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-77694000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,586000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,155000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23707000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47389000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-100635000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-100635000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-217000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9783000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9783000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,514000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,514000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,514000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,254000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-90084000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:18:11+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-101191000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-101191000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,921000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1433000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-30313000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18941000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-110209000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-110209000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1991000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-55000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-181991000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-181991000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,291035000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,95833000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,386868000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,386868000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-461000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94207000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89865000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89865000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,990000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1027000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21538000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6116000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-72426000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-72426000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5555000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-105555000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-105555000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-148000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,740000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,592000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,592000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-79000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-177468000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5594000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-99259000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-99259000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2104000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,908000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30953000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17433000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-82727000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-82727000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1479000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-180000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,195000000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13521000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13521000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,490000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-261000.0
Clovis Oncology Inc,CLVS,,0001466301,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-68977000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86421000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86421000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1722000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,516000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17077000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31345000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-98451000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-98451000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1231000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15000000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-138415000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,153500000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1146000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1146000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1093000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1093000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1093000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-64000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-98568000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 15:12:05+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120429000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120429000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1910000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-76000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,36400000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15842000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-98037000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-98037000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-253000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-750000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67364000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,143345000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,74978000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,74978000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6862000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1389000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8251000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8251000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,107000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14701000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1875000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-94073000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-94073000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2095000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,361000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15859000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18778000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-56980000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56980000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1403000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129325000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,275000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,183252000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,52799000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,52799000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-169853000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,267147000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,97338000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,97338000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-283000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,92874000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3171000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-99501000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-99501000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2041000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,536000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13272000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13505000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-70147000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-70147000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-403000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124731000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,141901000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16767000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16767000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1115000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13741000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,740000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-160000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13206000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13206000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,526000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39648000.0
Clovis Oncology Inc,CLVS,,0001466301,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1875000.0
